Clinica Baviera - Asset Resilience Ratio

Latest as of June 2025: 14.23%

Clinica Baviera (CBAV) has an Asset Resilience Ratio of 14.23% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read CBAV current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

€31.63 Million

≈ $36.98 Million USD Cash + Short-term Investments

Total Assets

€222.25 Million

≈ $259.84 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2006–2024)

This chart shows how Clinica Baviera's Asset Resilience Ratio has changed over time. See CBAV net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Clinica Baviera's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see CBAV stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€31.63 Million	14.23%
Total Liquid Assets	€31.63 Million	14.23%

Asset Resilience Insights

Moderate Liquidity: Clinica Baviera has 14.23% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Clinica Baviera Industry Peers by Asset Resilience Ratio

Compare Clinica Baviera's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Revvity Inc. NYSE:RVTY	Diagnostics & Research	0.00%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Fleury S.A. SA:FLRY3	Diagnostics & Research	16.19%
Shanghai Labway Clinical Laboratory Co Ltd SHE:301060	Diagnostics & Research	2.10%
Genoray Co. Ltd KQ:122310	Diagnostics & Research	0.03%
Bcal Diagnostics Ltd AU:BDX	Diagnostics & Research	0.00%
Avricore Health Inc V:AVCR	Diagnostics & Research	0.75%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%

Annual Asset Resilience Ratio for Clinica Baviera (2006–2024)

The table below shows the annual Asset Resilience Ratio data for Clinica Baviera.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	13.42%	€28.44 Million ≈ $33.25 Million	€211.95 Million ≈ $247.80 Million	-10.62pp
2023-12-31	24.03%	€42.93 Million ≈ $50.19 Million	€178.64 Million ≈ $208.85 Million	-1.94pp
2022-12-31	25.98%	€38.99 Million ≈ $45.58 Million	€150.10 Million ≈ $175.49 Million	+1.86pp
2021-12-31	24.12%	€32.27 Million ≈ $37.73 Million	€133.81 Million ≈ $156.44 Million	+1.84pp
2020-12-31	22.28%	€26.94 Million ≈ $31.49 Million	€120.92 Million ≈ $141.37 Million	+19.75pp
2019-12-31	2.53%	€2.57 Million ≈ $3.00 Million	€101.56 Million ≈ $118.74 Million	-8.03pp
2018-12-31	10.56%	€5.89 Million ≈ $6.89 Million	€55.83 Million ≈ $65.27 Million	-1.55pp
2017-12-31	12.11%	€6.54 Million ≈ $7.64 Million	€53.99 Million ≈ $63.12 Million	-4.57pp
2016-12-31	16.68%	€7.80 Million ≈ $9.12 Million	€46.77 Million ≈ $54.68 Million	-1.70pp
2015-12-31	18.38%	€8.52 Million ≈ $9.97 Million	€46.38 Million ≈ $54.22 Million	-2.54pp
2014-12-31	20.92%	€10.26 Million ≈ $11.99 Million	€49.04 Million ≈ $57.33 Million	-0.99pp
2013-12-31	21.91%	€10.58 Million ≈ $12.37 Million	€48.28 Million ≈ $56.44 Million	+20.59pp
2007-12-31	1.32%	€596.82K ≈ $697.75K	€45.25 Million ≈ $52.90 Million	-0.03pp
2006-12-31	1.35%	€585.35K ≈ $684.34K	€43.39 Million ≈ $50.73 Million	--

pp = percentage points

About Clinica Baviera

MC:CBAV Spain Diagnostics & Research

Market Cap

$1.04 Billion

€893.60 Million EUR

Market Cap Rank

#9903 Global

#69 in Spain

Share Price

€55.80

Change (1 day)

+3.33%

52-Week Range

€37.00 - €55.80

All Time High

€55.80